WASHINGTON, June 24, 2021 – On June 24, 2021, the Alliance for Aging Research (“Alliance) submitted written comment to the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) outlining its recommendations for approaching pneumococcal vaccines. The Alliance’s recommendations include:
- ACIP Should Prioritize Recruitment of Members with Geriatric Expertise
- CDC/ACIP Should Leverage the Pharmacy Partnership for Long-Term Care (LTC) Program for All Older Adult Vaccines
- HHS/CDC Should Remove Economic Considerations and Analyses from the ACIP Charter
Click here to read the comments.
About the Alliance for Aging Research
The Alliance for Aging Research is the leading nonprofit organization dedicated to accelerating the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health. The Alliance believes advances in research help people live longer, happier, more productive lives and reduce healthcare costs over the long term. For more than 30 years, the Alliance has guided efforts to substantially increase funding and focus for aging at the National Institutes of Health and Food and Drug Administration; built influential coalitions to guide groundbreaking regulatory improvements for age-related diseases; and created award-winning, high-impact educational materials to improve the health and well-being of older adults and their family caregivers. For more information, visit www.agingresearch.org